Trials / Unknown
UnknownNCT00395915
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia. An Independent, Pragmatic, Multicentre, Parallel-Group, Superiority Trial.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Universita di Verona · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The principal clinical question to be answered by CHAT (Clozapine Haloperidol Aripiprazole Trial) is the relative efficacy and tolerability of combination treatment with clozapine plus aripiprazole compared to combination treatment with clozapine plus haloperidol in patients with an incomplete response to treatment with clozapine over an appropriate period of time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | aripiprazole |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2009-03-01
- Completion
- 2009-12-01
- First posted
- 2006-11-06
- Last updated
- 2009-02-18
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00395915. Inclusion in this directory is not an endorsement.